Regeneron Pharmaceuticals Inc REGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
962.49UNCH (UNCH)
Volume
52,795
Close
962.49UNCH (UNCH)
Volume
408,984
52 week range
684.80 - 998.33
Loading...
  • Open970.38
  • Day High970.79
  • Day Low959.25
  • Prev Close966.30
  • 52 Week High998.33
  • 52 Week High Date02/28/24
  • 52 Week Low684.80
  • 52 Week Low Date06/28/23

Key Stats

  • Market Cap105.645B
  • Shares Out109.76M
  • 10 Day Average Volume0.46M
  • Dividend-
  • Dividend Yield-
  • Beta0.11
  • YTD % Change9.59

KEY STATS

  • Open970.38
  • Day High970.79
  • Day Low959.25
  • Prev Close966.30
  • 52 Week High998.33
  • 52 Week High Date02/28/24
  • 52 Week Low684.80
  • 52 Week Low Date06/28/23
  • Market Cap105.645B
  • Shares Out109.76M
  • 10 Day Average Volume0.46M
  • Dividend-
  • Dividend Yield-
  • Beta0.11
  • YTD % Change9.59

RATIOS/PROFITABILITY

  • EPS (TTM)34.76
  • P/E (TTM)27.69
  • Fwd P/E (NTM)21.47
  • EBITDA (TTM)4.654B
  • ROE (TTM)16.26%
  • Revenue (TTM)13.117B
  • Gross Margin (TTM)86.16%
  • Net Margin (TTM)30.14%
  • Debt To Equity (MRQ)10.41%

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic conditions, infectious diseases, and rare diseases. It helps in accelerating and improving the...
Christopher Fenimore
Chief Financial Officer, Senior Vice President - Finance
Daniel Van Plew
Executive Vice President, General Manager - Industrial Operations and Product Supply
Marion McCourt
Executive Vice President - Commercial
Andrew Murphy Ph.D.
Executive Vice President - Research
Neil Stahl Ph.D.
Executive Vice President - Research and Development
Jason Pitofsky
Vice President, Controller
Address
777 Old Saw Mill River Road
Tarrytown, NY
10591
United States

Top Peers

SYMBOLLASTCHG%CHG
BIIB
Biogen Inc
215.63UNCHUNCH
MRNA
Moderna Inc
106.56UNCHUNCH
NVZMY
Novozymes A/S
58.86+0.01+0.02%
ILMN
Illumina Inc
137.32UNCHUNCH
BNTX
Biontech SE
92.25UNCHUNCH